UnknownNCT04948528

Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection

Studying Upper tract urothelial carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AnchorDx Medical Co., Ltd.
Principal Investigator
Jian HUANG, MD, M.D. Ph.D
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Intervention
Active Comparator: Surgery Pathology or Cystoscopy(other)
Enrollment
490 target
Eligibility
18 years · All sexes
Timeline
2020 – 2023

Study locations (1)

Collaborators

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Peking University First Hospital · Peking University Third Hospital · Peking Union Medical College Hospital · The Affiliated Hospital of Qingdao University · First Affiliated Hospital, Sun Yat-Sen University · Sir Run Run Shaw Hospital · The First Affiliated Hospital of Zhengzhou University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04948528 on ClinicalTrials.gov

Other trials for Upper tract urothelial carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Upper tract urothelial carcinoma →

← Back to all trials